Jasper Therapeutics Inc.
(JSPR)
undefined
undefined%
At close: undefined
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
Net Income | -64.47M | -37.69M | -30.64M | -31.67M | -4.99M |
Depreciation & Amortization | 1.11M | 975.00K | 377.00K | 21.00K | - |
Stock-Based Compensation | 5.21M | 4.09M | 1.05M | 1.21M | 6.00K |
Other Working Capital | 2.06M | 1.50M | -1.32M | 938.00K | 1.39M |
Other Non-Cash Items | 976.00K | -12.59M | -9.09M | 10.90M | 1.62M |
Deferred Income Tax | - | - | 3.00M | -21.00K | - |
Change in Working Capital | 5.10M | -649.00K | 1.62M | 1.30M | 1.39M |
Operating Cash Flow | -52.07M | -45.86M | -33.68M | -18.27M | -1.97M |
Capital Expenditures | -267.00K | -576.00K | -2.43M | - | - |
Acquisitions | - | - | - | - | - |
Purchase of Investments | - | - | - | - | - |
Sales Maturities Of Investments | - | - | - | - | - |
Other Investing Acitivies | - | - | - | 198.34K | - |
Investing Cash Flow | -267.00K | -576.00K | -2.43M | 198.34K | - |
Debt Repayment | - | - | - | - | 1.50M |
Common Stock Repurchased | - | 28.00K | - | - | - |
Dividend Paid | - | - | - | - | - |
Other Financial Acitivies | -56.00K | 55.00K | 100.97M | 11.29M | 27.63M |
Financial Cash Flow | 100.97M | 55.00K | 100.97M | 11.29M | 29.13M |
Net Cash Flow | 48.64M | -46.38M | 64.86M | -6.98M | 27.16M |
Free Cash Flow | -52.33M | -46.43M | -36.11M | -18.27M | -1.97M |